Skip to content
The Hematologist cover art

All Episodes

The Hematologist — 168 episodes · page 1 of 2

#
Title
1

One on One With Mary Horowitz

2

A Secondary Consideration: How Real-World Evidence Can Inform Practice in the Management of Patients With Secondary CNS Lymphoma

3

Targeting the Lectin Pathway in Hematopoietic Stem Cell Transplant-Associated Thrombotic Microangiopathy

4

Search for the Fountain of Youth: Can Bispecific Antibodies Resurrect Dysfunctional T Cells to Improve Outcomes in Richter Transformation?

5

Not All Clots Are Created Equal: Refining Secondary Prevention of Venous Thromboembolism in Higher-Risk Patients

6

Continuous Versus Fixed-Duration Treatment for Frontline Chronic Lymphocytic Leukemia

7

VERONA and the Future of High-Risk Myelodysplastic Syndromes: A Conversation With Dr. Jacqueline Garcia

8

Leading With Lived Experience: Dr. Brian Koffman, Patient and CEO of the CLL Society

9

An Homage to the Treg Graft in Allogeneic Transplantation

10

Less Is More: Low-Dose Direct Oral Anticoagulants for Extended Venous Thromboembolism Prophylaxis in Higher-Risk Patients

11

GATA Lot to Learn: Decoding the Drivers of Down Syndrome-Associated Acute Leukemias

12

More Than Medicine: Peer Connection as a Therapeutic Adjunct in Acute Leukemia

13

Pomalidomide: A Step on the PATH Forward for Treatment of Hereditary Hemorrhagic Telangiectasia

14

Dual BCR::ABL1 Inhibition Shows Promise in Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia

15

When to STOP Treatment for Immune Thrombocytopenia in Patients Experiencing a Complete Response on Thrombopoietin Receptor Agonists

16

No Scientific Link Found Between Sickle Cell Trait and Sudden Death

17

Does This Star ‘GLO’? Taking Aim at Second-Line Diffuse Large B-Cell Lymphoma With Glofitamab Plus Gemcitabine and Oxaliplatin

18

The Rise of the HLA-Mismatched Unrelated Donor Transplant in the U.S.

19

The End of Transplant for Mantle Cell Lymphoma

20

DREAMMing of a Better Tomorrow: Belantamab-Based Triplet Therapy for Relapsed/Refractory Multiple Myeloma

21

Haploidentical Stem Cell Transplantation Is an Acceptable Transformative Therapy for Young Adults With Sickle Cell Disease

22

Enhancing Risk Stratification for Pediatric B-Cell Acute Lymphoblastic Leukemia: No Longer a ‘PI’ in the Sky Idea?

23

A Leap of Faith? Elimination of Autologous Stem Cell Transplantation for Patients With Mantle Cell Lymphoma in First Remission

24

Anticoagulation Stewardship

25

Blood Global Hematology Editor-in-Chief Shares Vision

26

One on One With Dr. Fred Appelbaum

27

Genetic Switch System Suggests Targeting of Mutant JAK2 Reverses Myeloproliferative Neoplasms

28

Venous Thromboembolism Risk Markers and Discontinuing Combined Hormonal Contraceptives

29

Growing the Next Generation of Hematologists

30

Women in Hematology

31

Four Is Better Than Three: Will We Finally Agree?

32

Toward Equity in Access for ALL

33

The Brilliant Success of Blinatumomab for Babies With Acute Lymphoblastic Leukemia

34

Editors-in-Chief of Two New ASH Journals Share Their Visions

35

ASH’s Minority Recruitment Initiative Mentorship Program Offers a Win for All

36

Results From the Blood and Marrow Transplant Trials Network: How Should We Prevent Graft-versus-host Disease in 2023?

37

Genetic Background Influences the Growth of CHIP Clones Within the Bone Marrow, With Drs. Robert Hasserjian and Siddhartha Jaiswal

38

Drawing New Blood Into Hematology

39

Anticoagulation and Abnormal Uterine Bleeding: Acknowledging Calls to Action

40

ASH | FDA Collaboration: A Workshop on Regulatory Science in Hematology

41

The Next Wave of T-cell Engagement for the Management of Diffuse Large B-cell Lymphoma, with Drs. Michael Dickinson and Loretta J. Nastoupil

42

VTE Guidelines for Latin America Special Populations and Diagnosis (Portuguese Audio)

43

VTE Guidelines for Latin America Special Populations and Diagnosis (Spanish Audio)

44

VTE Guidelines for Latin America Special Populations and Diagnosis (English Audio)

45

ASH Summit on Immunotherapies for Hematologic Diseases, With Dr. Terry Fry and Dr. Shaji Kumar

46

GPRC5D: The Next Frontier for Immunotherapy in Multiple Myeloma, With Drs. Shaji Kumar and Saad Usmani

47

Should Minimal Residual Disease Guide the Way? With Drs. Partow Kebriaei and Lori Muffly

48

ASH Celebrates Hispanic Heritage Month, With Drs. Ruben Mesa, Diego Adrianzen-Herrera, & Joanna Robles, Introduced by Dr. Belinda Avalos

49

ASH Celebra el Mes de la Herencia Hispana, Con el Dr. Ruben Mesa, el Dr. Diego Adrianzen-Herrera, & la Dra. Joanna Robles

50

Iron-restricted Erythropoiesis in Sickle Cell Disease, With Drs. David Rees, Naja Nyffenegger, & Vania Manolova

51

ASH and Maternal Health, With Drs. Jennifer Holter-Chakrabarty & Sarah O’Brien

52

Trust Your Gut: Changes in Intestinal Microbiome Are Associated With Outcomes Following CAR-T Therapy, With Drs. Loretta Nastoupil & Melody Smith

53

The Latest Sickle Cell Disease Policy Updates, With Drs. Jennifer Holter Chakrabarty & Chancellor Donald

54

Structural Racism and Understanding Disparities in AML Outcomes, With Drs. Christine McMahon & Ivy Abraham

55

A Conversation About Women in Medicine, With Drs. Shikha Jain and Laura Michaelis

56

ASH VTE-LA Guidelines: Prevention of VTE in Latin America, With Drs. Patricia Casais & Luis Meillon-Garcia

57

Modelling Myelofibrosis in Vivo: Success With NSG-S, With Drs. Beth Psaila and Hamza Celik

58

Guías TEV-LA: Prevención de TEV en América Latina, Con Dras. Cecilia Colorio y Cecilia Guillermo

59

Diretrizes TEV-LA: Prevenção de TEV na América Latina, Com Dr. Suely Rezende e Daniel Ribeiro

60

An Interview With Pediatric Physician Scientist, Advocate, and Mentor Dr. Rayne Rouce

61

From Myth to Reality: Achieving Second Remission in ALL, With Drs. Kristen O'Dwyer & Laura Michaelis

62

2021 ASH Annual Meeting: Plenary Abstract on ZUMA-7 Study, With Drs. Frederick Locke & Brad Kahl

63

2021 ASH Annual Meeting: COVID-19 Content at the Meeting, With Drs. Cindy Dunbar and Laura Michaelis

64

2021 ASH Annual Meeting: Plenary Abstract on ATLAS-INH in Patients With Hemophilia A or B With Inhibitors, Drs. Guy Young & Laura Michaelis

65

Weighing the Risks and Benefits of DOACs in Morbidly Obese Patients, With Drs. Damon Houghton & Karlyn Martin

66

ASH VTE Guidelines & COVID-19 Update: Use of Anticoagulation in Patients With COVID-19, With Drs. Laura Michaelis, Adam Cuker & Reem Mustafa

67

Genome Editing: Fetal Origins of AML in Down Syndrome, With Drs. Adam Mead & Elvin Wagenblast

68

ASH ICAL Next-generation Sequencing Program, Drs. Peter Valk, Torsten Haferlach & Pamela Mora

69

COVID-19 Update 18: ASH RC COVID-19 Registry for Hematology, Drs. Michaelis, Hicks, Wood, & Desai

70

COVID-19 Update 17: COVID-19 Vaccines, With Drs. Laura Michaelis, Jeffery Auletta & Adrian Wiestner

71

Clonal Hematopoiesis and Risk of T-MN, With Drs. Amy DeZern & Kelly Bolton

72

ASH Advocacy & New Administration Health Care Priorities With Drs. Donald & Holter-Chakrabarty

73

Year's Best: The BELLINI Study, With Drs. Irene Ghobrial and Shaji Kumar

74

2020 ASH Annual Meeting: A Guide for Trainees, With Drs. Ajay Major and Lachelle Weeks

75

2020 ASH Annual Meeting: Disparities in Science, With Drs. Laura Michaelis & Chancellor Donald

76

Is Dose-adjusted EPOCH-R Enough for Burkitt Lymphoma? With Drs. Brad Kahl and Mark Roschewski

77

Get Involved With ASH Advocacy, With Drs. Chancellor Donald, Alan Rosmarin, & Laura Michaelis

78

COVID-19 Update 15: The Latest ASH Resources, With Drs. Stephanie Lee and Laura Michaelis

79

COVID-19 Update 14: The Latest on Convalescent Plasma, With Drs. Laura Michaelis and Evan Bloch

80

Does the Immune System Matter in Treatment for AML? With Drs. Steven Lane & Sergio Rutella

81

ASH Meeting on Hematologic Malignancies: A Virtual Experience, With Drs. Smith, Rajkumar, & Roboz

82

COVID-19 Update 13: How Pandemic Affects Labs & Early-Career Researchers, Drs. Michaelis & Levine

83

COVID-19 Update 12: PTSD in Health Care Providers During COVID-19, With Drs. Michaelis & Back

84

COVID-19 Update 11: How COVID-19 Is Affecting Clinical Trainees, With Drs. Michaelis & Alice Ma

85

COVID-19 Update 10: Anticoagulation in Patients With COVID-19, With Drs. Laura Michaelis & Agnes Lee

86

COVID-19 Update 9: ASH RC COVID-19 Registry, With Drs. Laura Michaelis, Lisa Hicks, and Bill Wood

87

COVID-19 Update 8: Managing the Blood Supply During COVID-19, With Drs. Michaelis & Margo Rollins

88

Gut Microbiome Diversity Influences Transplant Risk With Drs. Steven Lane & Jonathan Peled

89

COVID-19 Update 7: Managing Patients With SCD During COVID-19 Crisis, With Drs. Michaelis & Osunkwo

90

COVID-19 Update 6: Hematologists on the Front Lines, With Drs. Michaelis, Phillips, & Abu-Zeinah

91

COVID-19 Update 5: Convalescent Serum Studies, With Drs. Laura Michaelis and Parameswaran Hari

92

COVID-19 Update 4: Supporting Nurses, APPs, & Physicians With Drs. Laura Michaelis & Rachel Yehuda

93

COVID-19 Update 3: Social Media for Information Dissemination, Drs. Laura Michaelis & David Steensma

94

COVID-19 Update 2: Updates From New York City, With Drs. Stephanie Lee and Martin Tallman

95

How ASH Supports the Hematology Community During COVID-19, With Drs. Stephanie Lee & Laura Michaelis

96

How FLT3-ITDs & NPM1 Insertions Maneuver Into AML Using Lymphoid Enzyme TdT With Drs. Kim & Borrow

97

ASH-LLS Clinical Trial Support Center Collaboration With Drs. Gwen Nichols & Jennifer Holter

98

Year's Best in SCD: A Global Perspective on Pregnancy in 2019 With Drs. Osunkwo & Michaelis

99

The Hematologist & ASH News Daily Editors on Contributing to ASH Pubs With Drs. Michaelis and Zia

100

Navigating the 2019 ASH Annual Meeting: PhDs, With Drs. Andrew Volk and Heather O'Leary